Healthcare shares were mixed in pre-market trade Friday.
In healthcare stocks news, Isis Pharmaceuticals (
) shares were up 6% after it said a study of its ISIS-SMN Rx drug
in children with spinal muscular atrophy showed an average increase
of 3.7 points observed in muscle function score.
The children were treated with 9 pm of the drug, which also
showed dose-dependent increases in SMN protein levels in children
treated with ISIS-SMNRx from both single- and multiple-dose
studies. Isis said the drug was well tolerated at all dose
And, Teleflex Inc. (
), a provider of medical technology products, said Q4 adjusted
profit rose 18.3%, topping analysts' forecasts, helped by the
acquisitions of Vidacare and LMA International, a gain in average
selling prices and new products.
Q4 adjusted diluted earnings per share from continuing
operations were $1.36, compared to $1.15 in the prior year period.
That's above the $1.27 analyst estimate, according to Capital